Concepedia

Melissa Rijken

MR

Statistics

Publications

4

Citations

533

H-Index

4

Active since

2018

Affiliations

Erasmus MC Cancer Institute(Current)

Isala

University Hospital of Zurich

Máxima Medisch Centrum

Ministry of Health

Melissa Rijken is an author at Erasmus MC Cancer Institute specializing in tumor biology, cancer research, and molecular oncology.

Top concepts

Publications per year

2018–2024

4

Publications

4

Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome

Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders et al. · Blood · 2022 · 272 citations · Full text

, , +18

Prognostic Value of <i>FLT3</i>-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia

Tim Grob, Mathijs A. Sanders, Christian M. Vonk et al. · Journal of Clinical Oncology · 2022 · 128 citations · Full text

MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML

Mathijs A. Sanders, Edward Chew, Christoffer Flensburg et al. · Blood · 2018 · 114 citations · Full text

Risk Stratification in Older Intensively Treated Patients With AML

Jurjen Versluis, Marlen Metzner, Ariel Wang et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

1–4 of 4